DongKoo Bio & Pharma   Report issue

For profit Phase 1
Founded: Hwaseong Korea, Republic of (2014)

Organization Overview

First Clinical Trial
2018
NCT03438955
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

DongKoo Bio & Pharma